These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 32152343)
41. Optimal transformations leading to normal distributions of positron emission tomography standardized uptake values. Scarpelli M; Eickhoff J; Cuna E; Perlman S; Jeraj R Phys Med Biol; 2018 Jan; 63(3):035021. PubMed ID: 29235988 [TBL] [Abstract][Full Text] [Related]
42. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
43. 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes. Koo HR; Park JS; Kang KW; Cho N; Chang JM; Bae MS; Kim WH; Lee SH; Kim MY; Kim JY; Seo M; Moon WK Eur Radiol; 2014 Mar; 24(3):610-8. PubMed ID: 24097303 [TBL] [Abstract][Full Text] [Related]
44. High expression of HNRNPR in ESCA combined with Liu XY; Gao Y; Kui XY; Liu XS; Zhang YH; Zhang Y; Ke CB; Pei ZJ J Transl Med; 2022 Oct; 20(1):450. PubMed ID: 36195940 [TBL] [Abstract][Full Text] [Related]
45. Classification of Physiological 18F-fluorodeoxyglucose Uptake in the Large Intestine: a Preliminary Study. Yasuda S; Kobayashi K; Ono M; Miyatake Y; Miyauchi M; Kato T; Tanaka T; Ito M; Yamamoto N Tokai J Exp Clin Med; 2014 Sep; 39(3):141-5. PubMed ID: 25248430 [TBL] [Abstract][Full Text] [Related]
46. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer. Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804 [TBL] [Abstract][Full Text] [Related]
47. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET. Lu L; Jiang L; Guan H; Gao Y; Lu H Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052 [TBL] [Abstract][Full Text] [Related]
48. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma. Yamane T; Takaoka A; Kita M; Imai Y; Senda M Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262 [TBL] [Abstract][Full Text] [Related]
50. Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer. Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Shirabe K Anticancer Res; 2018 Aug; 38(8):4927-4931. PubMed ID: 30061271 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography. Maddalena F; Lettini G; Gallicchio R; Sisinni L; Simeon V; Nardelli A; Venetucci AA; Storto G; Landriscina M Mol Imaging; 2015; 14():490-8. PubMed ID: 26461458 [TBL] [Abstract][Full Text] [Related]
52. The role of Lee JW; Seo KH; Kim ES; Lee SM Eur Radiol; 2017 May; 27(5):1912-1921. PubMed ID: 27590191 [TBL] [Abstract][Full Text] [Related]
53. Effect of gemcitabine on the uptake of (18)F-fluorodeoxyglucose and (18)F-fluorothymidine in lung adenocarcinoma A549 cells and the animal tumor model. Zhang B; Deng SM; Guo LC; Dong JJ; Zhu YB; Gao Y; Wang ZX; Cho WC J Cancer Res Ther; 2016; 12(1):271-6. PubMed ID: 27072250 [TBL] [Abstract][Full Text] [Related]
54. PET Imaging of Hepatocellular Carcinomas: Zhao J; Zhang Z; Nie D; Ma H; Yuan G; Su S; Liu S; Liu S; Tang G Mol Imaging; 2019; 18():1536012118821032. PubMed ID: 30799682 [TBL] [Abstract][Full Text] [Related]
55. 3D tumour spheroids as a model to assess the suitability of [18F]FDG-PET as an early indicator of response to PI3K inhibition. Kelly CJ; Hussien K; Muschel RJ Nucl Med Biol; 2012 Oct; 39(7):986-92. PubMed ID: 22682985 [TBL] [Abstract][Full Text] [Related]
56. Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer. Usuda K; Sagawa M; Aikawa H; Ueno M; Tanaka M; Machida Y; Zhao XT; Ueda Y; Higashi K; Sakuma T Gen Thorac Cardiovasc Surg; 2010 Aug; 58(8):405-10. PubMed ID: 20703861 [TBL] [Abstract][Full Text] [Related]
57. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534 [TBL] [Abstract][Full Text] [Related]
58. The correlation of Qu YH; Long N; Ran C; Sun J Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540 [TBL] [Abstract][Full Text] [Related]
59. Positron Emission Tomography With 18F-Fluorodeoxyglucose in Patients With Sickle Cell Acute Chest Syndrome. de Prost N; Sasanelli M; Deux JF; Habibi A; Razazi K; Galactéros F; Meignan M; Maître B; Brun-Buisson C; Itti E; Dessap AM Medicine (Baltimore); 2015 May; 94(18):e821. PubMed ID: 25950690 [TBL] [Abstract][Full Text] [Related]
60. 18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats. Li P; Liu Q; Wang X; Huang G; Song S Med Sci Monit; 2019 Jan; 25():558-564. PubMed ID: 30659557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]